AGT and hepatocellular carcinoma: This was illustrated in the human IR-expressing rat hepatoma cell line where GPCR agonists such as bombesin, bradykinin, angiotensin I and angiotensin II, were shown to dose-dependently induce NEU1 sialidase activity and IR signaling in the complete absence of insulin.